Silence Therapeutics (NASDAQ: SLN) reported top-line results from its Phase II SANRECO trial of dive

Silence Therapeutics NASDAQ: SLN reported top-line results from its Phase II SANRECO trial of divesi

Silence Therapeutics plc (SLN) Discusses Top-Line Results From SANRECO Phase II Trial of Divesiran i

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc (“Silence” or the “Compan

Gainers Jin Medical International (NASDAQ:ZJYL) shares rose 58.1% to $3.4 during Monday's regul

Silence Therapeutics plc (NASDAQ:SLN) stock is trading higher on Monday after the company reported p

BWMN gained 55.1%, HZO rose 45.8%, ABCL gained 35.6%, SLN rose 34.3%, ACHR gained 19.5%, NESR gained

Gainers Jin Medical International (NASDAQ:ZJYL) stock rose 70.7% to $3.67 during Monday's pre-m

Silence Therapeutics plc, (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (sho

Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage biotechnology company developing nov

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc (Nasdaq: SLN), a global c

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc, (Nasdaq: SLN), a global

Avalon Holdings (NYSE:AWX) shares rose 10.5% in pre-market trading after posting strong Q2 earnings

Silence Therapeutics plc, (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (sho

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc, (Nasdaq: SLN), a global

Silence Therapeutics shares surge as investors eye key 2026 divesiran data, an advancing RNAi pipeli

Silence Therapeutics (SLN) was a big mover last session on higher-than-average trading volume. The l

I initiate Silence Therapeutics at a speculative Buy, driven by near-term divesiran/SLN124 catalysts

Silence Therapeutics (SLN) saw its shares surge in the last session with trading volume being higher

Silence Therapeutics Plc (NASDAQ:SLN) stock rose Wednesday after Cantor Fitzgerald initiated coverag

Silence Therapeutics ($SLN) stock surges as Cantor predicts key August Phase 2 data will be a major

Silence Therapeutics Plc (NASDAQ:SLN) shares are up during Friday's session. On Thursday, the compan

Silence Therapeutics says SANRECO data show sustained polycythemia vera benefits as analysts weigh d

Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage biotechnology company developing nov

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc (Nasdaq: SLN), a global c

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc (Nasdaq: SLN), a global c

Urgent.ly shares surged in pre-market trading after agreement to be acquired by Agero for $5.50 per

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarte

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for it

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl

  Tuesday's session saw 286 companies set new 52-week lows.

  On Monday, 147 stocks made new 52-week lows.

  During Friday's session, 149 stocks hit new 52-week lows.

  On Wednesday, 81 companies hit new 52-week lows.

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on T

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66.

  On Friday, 1043 companies hit new 52-week lows.

  Wednesday's session saw 784 companies set new 52-week lows.

    During Tuesday's trading, 505 companies set new 52-week lows.

    During Monday's morning trading, 285 companies set new 52-week highs.

    Friday morning saw 331 companies set new 52-week highs.

    This morning 194 companies reached new 52-week highs.

    Monday morning saw 558 companies set new 52-week highs.